Associate Vice President of Enterprise Business Development

Agilent Technologies

1d•Remote

About The Position

At Agilent, we’re on a collective quest to improve the world around us. As a global leader in laboratory technologies, we support scientists in 110 countries in cutting-edge life science research, patient diagnostics and their efforts to ensure the safety of water, food and pharmaceuticals. Our people create some of the world’s leading-edge laboratory technology and work side by side with customers to help them maximize productivity and achieve superior scientific outcomes. We do this important work in a diverse environment built on a foundation of trust, respect, and uncompromising integrity. Whatever the challenge, we come together to deliver trusted answers to our customers’ critical questions – bringing great science to life. The Role Reporting directly to the Chief Strategy & Corporate Development Officer, the Associate Vice President (AVP) of Enterprise Business Development is a core member of the Strategy & Corporate Development Leadership Team. This individual serves as a key partner to the Group level Business Development Leads, partnering on the overall health of Agilent’s M&A pipeline, Long Rang Plan (LRP) execution, enterprise strategy delivery, and deal advancement. The AVP Enterprise Business Development is responsible for the overall M&A pipeline health of the enterprise, will manage regular M&A pipeline meetings with Agilent’s CEO, and partner with Agilent’s most senior leaders to make tradeoff decisions on strategic M&A opportunities across the enterprise. They will also set standard work for M&A investment thesis development and pipeline management across the enterprise. The AVP Enterprise Business Development utilizes a combination of strong business acumen, strategic thinking, in-depth domain knowledge, and established industry contacts to advance inorganic growth strategies, working closely with group-level strategy teams. This individual will serve as a key architect of the company’s external growth engine. The AVP Enterprise Business Development is responsible for identifying, cultivating, and evaluating cross-group and adjacent M&A opportunities In addition, the AVP Enterprise Business Development contributes to the formulation of Agilent's long-range enterprise strategy, partnering with the Enterprise Strategy team to determine landscape of various strategic segments.

Requirements

Demonstrated strategic ability and experience in creating and executing multi-year strategic plans at the company, group, or business unit level.
Expertise in forming inorganic growth strategies that support business goals, including the identification, cultivation, and strategic rationale development for M&A targets.
Experience in conducting adjacency analyses in collaboration with stakeholders to explore non-core inorganic opportunities.
Proven capacity to engage, influence, and earn the trust of senior executives and peers at the executive level.
Relevant understanding of platforms, technologies/science, and market dynamics pertinent to the business.
Ability to identify, negotiate, and close business development and strategic collaboration opportunities, such as partnerships, licensing, and acquisitions, in close collaboration with Agilent partners.
MBA or technical degree relevant to life sciences.
10+ years of experience in M&A business development, corporate development, business consulting, or related roles, including increasing management responsibilities.
Proven track record of results driven by interpersonal and relationship-building skills, particularly in leading multicultural and geographically dispersed teams within a fast-paced, matrixed environment.

Responsibilities

Enterprise M&A Funnel Coordination: The AVP is responsible for managing the enterprise wide M&A funnel, ensuring robustness of the pipeline, enterprise wide adherence to standard work, and managing monthly M&A pipeline review meetings with Agilent’s CEO
Target Cultivation of Cross Group and Adjacent Deals: Partner with SCD Enterprise Strategy team to determine the company landscape of various priority strategic segments - maintaining a "living" pipeline of cross-group and adjacent targets that align with Agilent’s ever evolving enterprise strategy. Facilitates the active engagement and cultivation of these high-priority M&A targets.
Investment Thesis Development on Cross Group and Adjacent Deals: Partners with Agilent senior leadership and Group BD to design investment theses and define the main strategic assumptions for cross Group and adjacent M&A targets, leading strategic diligence efforts for these opportunities.
Cross-Functional Alignment: Acts as a key M&A leader advising and aligning Group Business Development leaders, General Managers, Group Presidents, and SCD staff on inorganic opportunities.